Trial Profile
Safety and efficacy evaluation of two doses of HFA-propelled beclomethasone dipropionate (QVAR) versus placebo by breath operated and metered dose inhalers in mild to moderate asthmatic children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D
- 31 Mar 2008 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 31 Mar 2008.
- 31 Mar 2008 Teva-Pharmaceutical-Industries added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 22 Dec 2007 Status changed from in progress to completed.